| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Shinichiro Ochi, Hiromi Tagata, Naomi Hasegawa, Norio Yasui-Furukori, Jun-Ichi Iga, Hiroko Kashiwagi, Fumitoshi Kodaka, Hiroshi Komatsu, Takashi Tsuboi, Akira Tokutani, Shusuke Numata, Kayo Ichihashi, Toshiaki Onitsuka, Hiroyuki Muraoka, Hitoshi Iida, Kazutaka Ohi, Kiyokazu Atake, Taishiro Kishimoto, Hikaru Hori, Yoshikazu Takaesu, Masahiro Takeshima, Masahide Usami, Manabu Makinodan, Naoki Hashimoto, Michiko Fujimoto, Ryuji Furihata, Tatsuya Nagasawa, Hisashi Yamada, Junya Matsumoto, Kenichiro Miura, Mikio Kido, Akitoyo Hishimoto, Shu-Ichi Ueno, Koichiro Watanabe, Ken Inada, Ryota Hashimot. Clozapine treatment is associated with higher prescription rate of antipsychotic monotherapy and lower prescription rate of other concomitant psychotropics: A real-world nationwide study. The international journal of neuropsychopharmacology. 2022-06-20. PMID:35723038. |
although clozapine is effective for treatment-resistant schizophrenia (trs), the rate of clozapine prescription is still low. |
2022-06-20 |
2023-08-14 |
Not clear |
| Shinichiro Ochi, Hiromi Tagata, Naomi Hasegawa, Norio Yasui-Furukori, Jun-Ichi Iga, Hiroko Kashiwagi, Fumitoshi Kodaka, Hiroshi Komatsu, Takashi Tsuboi, Akira Tokutani, Shusuke Numata, Kayo Ichihashi, Toshiaki Onitsuka, Hiroyuki Muraoka, Hitoshi Iida, Kazutaka Ohi, Kiyokazu Atake, Taishiro Kishimoto, Hikaru Hori, Yoshikazu Takaesu, Masahiro Takeshima, Masahide Usami, Manabu Makinodan, Naoki Hashimoto, Michiko Fujimoto, Ryuji Furihata, Tatsuya Nagasawa, Hisashi Yamada, Junya Matsumoto, Kenichiro Miura, Mikio Kido, Akitoyo Hishimoto, Shu-Ichi Ueno, Koichiro Watanabe, Ken Inada, Ryota Hashimot. Clozapine treatment is associated with higher prescription rate of antipsychotic monotherapy and lower prescription rate of other concomitant psychotropics: A real-world nationwide study. The international journal of neuropsychopharmacology. 2022-06-20. PMID:35723038. |
we therefore hypothesized that the rate of antipsychotic monotherapy in patients with trs who were prescribed clozapine would be higher than that in patients with schizophrenia who were not prescribed clozapine. |
2022-06-20 |
2023-08-14 |
Not clear |
| Amy Jongkind, Michelle Hendriks, Koen Grootens, Aartjan T F Beekman, Berno van Meije. Evaluation of a Collaborative Care Program for Patients With Treatment-Resistant Schizophrenia: Protocol for a Multiple Case Study. JMIR research protocols. vol 11. issue 6. 2022-06-14. PMID:35700002. |
worldwide, undertreatment with clozapine and other effective treatment options exist for people with treatment-resistant schizophrenia (trs). |
2022-06-14 |
2023-08-14 |
Not clear |
| Sung Min Ma, Junghyun Lim, Chunsu Jiang, Luminita Luc. Esophagitis after Clozapine Use in a 61-Year-Old Woman with Refractory Schizophrenia. Case reports in psychiatry. vol 2022. 2022-06-13. PMID:35693728. |
esophagitis after clozapine use in a 61-year-old woman with refractory schizophrenia. |
2022-06-13 |
2023-08-14 |
Not clear |
| Sung Min Ma, Junghyun Lim, Chunsu Jiang, Luminita Luc. Esophagitis after Clozapine Use in a 61-Year-Old Woman with Refractory Schizophrenia. Case reports in psychiatry. vol 2022. 2022-06-13. PMID:35693728. |
we herein report a case of a 61-year-old woman with schizophrenia who developed hematemesis, fever, and tachycardia after the initiation of clozapine. |
2022-06-13 |
2023-08-14 |
Not clear |
| Andrea Boscutti, Guido Cereda, Matteo Lazzaretti, Paolo Enrico, Alessio Fiorentini, Cecilia Prunas, Antonio Callari, Elisa Fontana, Giuseppe Delvecchio, Paolo Brambill. Successful clozapine rechallenge after myopericarditis: a case report. International clinical psychopharmacology. vol 37. issue 4. 2022-06-06. PMID:35661661. |
the patient, a 31-year-old male with treatment-resistant schizophrenia (trs), developed dyspnea on exertion and chest pain on day 19 after the start of clozapine titration. |
2022-06-06 |
2023-08-14 |
Not clear |
| Ovais Wadoo, Javed Latoo, Majid Alabdulla, Yassin Eltorki, Sadaf Riaz, Mustafa Abdul Karim, Mohammed Abu-Hafizah, Shuja Reag. Clozapine prescribing practice and trends in Qatar: First national observational study. Brain and behavior. 2022-06-01. PMID:35647930. |
clozapine is the gold standard in the management of treatment-resistant schizophrenia. |
2022-06-01 |
2023-08-13 |
Not clear |
| Timothy David Tanzer, Thomas Brouard, Samuel Dal Pra, Nicola Warren, Michael Barras, Steve Kisely, Emily Brooks, Dan Siskin. Treatment strategies for clozapine-induced hypotension: a systematic review. Therapeutic advances in psychopharmacology. vol 12. 2022-05-31. PMID:35633931. |
clozapine is the most effective medication for treatment-refractory schizophrenia but is associated with significant adverse drug effects, including hypotension and dizziness, which have a negative impact on quality of life and treatment compliance. |
2022-05-31 |
2023-08-13 |
Not clear |
| Diana Grajales, Patricia Vázquez, Rosa Alén, Ana B Hitos, Ángela M Valverd. Attenuation of Olanzapine-Induced Endoplasmic Reticulum Stress Improves Insulin Secretion in Pancreatic Beta Cells. Metabolites. vol 12. issue 5. 2022-05-28. PMID:35629947. |
second-generation antipsychotics (sgas), in particular, olanzapine and clozapine, have been associated with the development of type 2 diabetes mellitus (t2d) and metabolic syndrome in individuals with schizophrenia. |
2022-05-28 |
2023-08-13 |
mouse |
| Juanjuan Ren, Yan Chen, Xinyu Fang, Dandan Wang, YeWei Wang, LingFang Yu, Zenan Wu, Ruimei Liu, Chen Zhan. Correlation of Orexin-A and brain-derived neurotrophic factor levels in metabolic syndrome and cognitive impairment in schizophrenia treated with clozapine. Neuroscience letters. 2022-05-26. PMID:35618081. |
correlation of orexin-a and brain-derived neurotrophic factor levels in metabolic syndrome and cognitive impairment in schizophrenia treated with clozapine. |
2022-05-26 |
2023-08-13 |
Not clear |
| Juanjuan Ren, Yan Chen, Xinyu Fang, Dandan Wang, YeWei Wang, LingFang Yu, Zenan Wu, Ruimei Liu, Chen Zhan. Correlation of Orexin-A and brain-derived neurotrophic factor levels in metabolic syndrome and cognitive impairment in schizophrenia treated with clozapine. Neuroscience letters. 2022-05-26. PMID:35618081. |
here, we aimed to investigate the relationship between orexin-a levels, bdnf, mets, clinical symptom profile, and cognitive function in schizophrenia patients following long-term clozapine treatment. |
2022-05-26 |
2023-08-13 |
Not clear |
| Ira R Katz, Benjamin R Szymanski, Stephen R Marder, Abigail Shotwell, Tyler C Hein, John F McCarthy, Nicholas W Bowerso. Comparative risks of all-cause mortality for Veterans with schizophrenia with ongoing receipt of clozapine and other antipsychotic medications. Psychiatry research. vol 313. 2022-05-14. PMID:35567853. |
comparative risks of all-cause mortality for veterans with schizophrenia with ongoing receipt of clozapine and other antipsychotic medications. |
2022-05-14 |
2023-08-13 |
Not clear |
| Silvia Moga, Andreea Teodorescu, Petru Ifteni, Paula-Simina Petric, Ana-Aliana Miro. Clozapine and Neutropenia in Patients with Schizophrenia and SARS-CoV-2 Infection. Neuropsychiatric disease and treatment. vol 18. 2022-05-13. PMID:35547265. |
clozapine and neutropenia in patients with schizophrenia and sars-cov-2 infection. |
2022-05-13 |
2023-08-13 |
Not clear |
| Silvia Moga, Andreea Teodorescu, Petru Ifteni, Paula-Simina Petric, Ana-Aliana Miro. Clozapine and Neutropenia in Patients with Schizophrenia and SARS-CoV-2 Infection. Neuropsychiatric disease and treatment. vol 18. 2022-05-13. PMID:35547265. |
clozapine (clz) is used for treatment-resistant schizophrenia (trs). |
2022-05-13 |
2023-08-13 |
Not clear |
| Silvia Moga, Andreea Teodorescu, Petru Ifteni, Paula-Simina Petric, Ana-Aliana Miro. Clozapine and Neutropenia in Patients with Schizophrenia and SARS-CoV-2 Infection. Neuropsychiatric disease and treatment. vol 18. 2022-05-13. PMID:35547265. |
we aimed to provide a study on the association between neutropenia and clozapine in patients with schizophrenia and covid-19. |
2022-05-13 |
2023-08-13 |
Not clear |
| Sung Woo Joo, Harin Kim, Young Tak Jo, Soojin Ahn, Young Jae Choi, Woohyeok Choi, Soyeon Park, Jungsun Le. Comparative effectiveness of antipsychotic monotherapy and polypharmacy in schizophrenia patients with clozapine treatment: A nationwide, health insurance data-based study. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 59. 2022-05-13. PMID:35550204. |
comparative effectiveness of antipsychotic monotherapy and polypharmacy in schizophrenia patients with clozapine treatment: a nationwide, health insurance data-based study. |
2022-05-13 |
2023-08-13 |
Not clear |
| Sung Woo Joo, Harin Kim, Young Tak Jo, Soojin Ahn, Young Jae Choi, Woohyeok Choi, Soyeon Park, Jungsun Le. Comparative effectiveness of antipsychotic monotherapy and polypharmacy in schizophrenia patients with clozapine treatment: A nationwide, health insurance data-based study. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 59. 2022-05-13. PMID:35550204. |
clozapine is the most effective antipsychotic for treatment-resistant schizophrenia (trs). |
2022-05-13 |
2023-08-13 |
Not clear |
| John Holden, Milia Begu. Successful rechallenge after clozapine-associated myocarditis. BMJ case reports. vol 15. issue 5. 2022-05-13. PMID:35550318. |
clozapine is a highly effective medication used in management of treatment-resistant schizophrenia. |
2022-05-13 |
2023-08-13 |
Not clear |
| Biswa Ranjan Mishra, Kanhaiyalal Agrawal, Tathagata Biswas, Debadatta Mohapatra, Santanu Nath, Rituparna Mait. Comparison of Acute Followed by Maintenance ECT vs Clozapine on Psychopathology and Regional Cerebral Blood Flow in Treatment-Resistant Schizophrenia: A Randomized Controlled Trial. Schizophrenia bulletin. 2022-05-13. PMID:35556138. |
comparison of acute followed by maintenance ect vs clozapine on psychopathology and regional cerebral blood flow in treatment-resistant schizophrenia: a randomized controlled trial. |
2022-05-13 |
2023-08-13 |
Not clear |
| Biswa Ranjan Mishra, Kanhaiyalal Agrawal, Tathagata Biswas, Debadatta Mohapatra, Santanu Nath, Rituparna Mait. Comparison of Acute Followed by Maintenance ECT vs Clozapine on Psychopathology and Regional Cerebral Blood Flow in Treatment-Resistant Schizophrenia: A Randomized Controlled Trial. Schizophrenia bulletin. 2022-05-13. PMID:35556138. |
in treatment-resistant schizophrenia (trs), clozapine is only approved treatment with undesirable side-effects, warranting better alternatives. |
2022-05-13 |
2023-08-13 |
Not clear |